CGM Use in Adults With Type 2 Diabetes on Basal Insulin

Inclusion Criteria:

• Aged 18 years or over.

• Type 2 diabetes diagnosis for ≥1 year prior to enrolment.

• Type 2 diabetes treated with a basal insulin injection regimen and SGLT2 inhibitorand/or GLP-1.

• Screening HbA1c ≥59 mmol/mol to ≤97 mmol/mol (≥7.5% and ≤11.0%, inclusive).

Exclusion Criteria:

• Participant is currently prescribed prandial or pre-mixed (biphasic) insulin atenrolment.

• Currently participating in another study that could affect glucose measurements orglucose management.

• A female participant who is pregnant.

• A breastfeeding female participant.

• Bariatric surgical procedure within the past 12 months or is planning/scheduled forbariatric surgery within the study duration.